Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Devazepide is a competitive and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor (IC50s: 81 pM, 45 pM, and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 68.00 | |
5 mg | 5 days | $ 128.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 152.00 |
Description | Devazepide is a competitive and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor (IC50s: 81 pM, 45 pM, and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively). |
Targets&IC50 | CCK receptor (guinea pig brain):245 nM, CCK receptor (rat pancreas):45 pM, CCK receptor (bovine gallbladder):81 pM |
Synonyms | L-364,718, MK-329 |
Molecular Weight | 408.45 |
Formula | C25H20N4O2 |
CAS No. | 103420-77-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Devazepide 103420-77-5 Others MK 329 MK329 L-364,718 MK-329 inhibitor inhibit